Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
34 results
D2.33 - Complex occupational allergic contact dermatitis: polysensitization in a worker exposed to metals, adhesives, and plastics
D2.34 - Pediatric allergic contact cheilitis associated with propolis sensitization
D2.35 - Occupational Protein Contact Dermatitis to Latex Compromising Fitness for Work in a Nurse
D2.37 - Occupational Allergic Dermatoses of the Face: Allergen Distribution and Work-Related Outcomes
D2.38 - Occupational Exposure to Propolis: A Rare Cause of Allergic Contact Dermatitis in Textile Workers
D2.39 - Occupational Contact Dermatitis with Polysensitization to Metals: Challenges for Work Fitness and Prevention
D2.40 - Occupational allergic contact dermatitis to metals: clinical features and impact on work fitness
D2.41 - Production of recombinant Cuc ma 5: A Step Towards Molecular Diagnosis of Pumpkin Seed Allergy
D2.42 - Evaluation of User Experience with a Skin Prick Automated Test (SPAT) Device compared to a Manual Skin Prick Test (SPT) in Pediatric Patients
D2.30 - A Case of Kimura’s Disease with Atypical Presentation and Novel Genetic Findings
D2.31 - A Case of Acquired C1 Inhibitor Deficiency Angioedema with Anti-C1q Antibodies in Systemic Lupus Erythematosus and Negative Exome Sequencing
D2.32 - A Positive Drug Challenge to Amoxicillin and Clavulanate (AMX) in a Child, Six Years After the Initial Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)
D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study
D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study
D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study
D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial
D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial
D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial
D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort
D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download